InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,905.22
(
0.98%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

elllk

Send PM Follow Ignore
Followers 22
Posts 1818
Boards Moderated 0
Alias Born 07/12/2003

elllk

Re: rocky301 post# 41748

Friday, 03/09/2012 4:09:27 PM

Friday, March 09, 2012 4:09:27 PM

Post# of 92948
Rocky is almost certainly correct. Here is an application to CIRM submitted by ISCO and rejected.

Parthenogenetic Stem Cell-Derived Corneal Tissue as an In Vitro Model for Ocular Injury
http://www.cirm.ca.gov/ReviewReports_RT1-01137-1


Re:

<<<<<<<<<<<<<<<
The following Working Group members had a conflict of interest with this application and were therefore recused from participating in review of, discussion of, and voting on the application:
? Cibelli, Jose
>>>>>>>>>>>>>>>

Interestingly, the above mentioned Jose Cibelli worked at ACTC many years ago when West was President and CSO and when Lanza first arrived.

http://www.mcdb.ucla.edu/Research/Goldberg/hc70a_w06/pdf/HumanClonedEmbryo.pdf
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up